| Drug Name | SOLIQUA )LIXISENATIDE, INSULIN GLARGINE) |
|---|---|
| Drug Class |
Anti-diabetic
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
Healthcare provider guide
|
| Specialty (Theraputic area) |
Endocrine
|
| Risk |
Important information on dosing |
| Health care provider guide |
|
| Dear Healthcare provider letter DHPC |
|